Navigation Links
CCNY professor gets grant to develop 'artificial blood'
Date:12/7/2010

As a post-doc at The University of Pennsylvania, Dr. Ron Koder, assistant professor of physics at The City College of New York, was part of a team that devised a novel method for producing an artificial protein capable of transporting oxygen, similar to human neuroglobin. He was recently awarded a three-year $1.3 million grant from the U.S. Department of Defense to develop an artificial blood that can be administered to injured troops on the battlefield.

"Engineered blood substitutes have a lot of attractive properties compared to blood drawn from people," he said. "No typing is required, you don't have to worry about refrigeration or freshness and there is no risk of infection." They can save lives, as well, since severely wounded servicemen and women sometimes die before they can be transported to a hospital and given a transfusion.

Professor Koder will use the grant to conduct laboratory studies to improve the stability and other properties of the protein. Then, he plans to cross-link the protein into large aggregates to create particles the same size as red blood cells.

Because the artificial hemoglobin binds oxygen in the presences of carbon monoxide, the substance also has the potential to prevent or treat carbon monoxide poisoning, he noted. However, this will not be part of the investigation.

Research like Professor Koder's investigation is part of the emerging field of biological design, a system for producing biological materials from scratch. Other potential applications include fighting AIDS and alternative energy. Biological design was the topic of a daylong symposium Friday, December 3, at the New York Academy of Sciences that Professor Koder helped organize.

"Natural materials are fussy. It's hard to get them to interact," he explained. "The (manmade) stuff is better for engineering more complex systems." Some of the biological design projects underway include developing metabolic pathways that could produce low-cost AIDS drugs, using solar energy to produce bio-fuels through artificial photosynthesis and making methanol from carbon dioxide.


'/>"/>

Contact: Ellis Simon
esimon@ccny.cuny.edu
212-650-6460
City College of New York
Source:Eurekalert

Related biology news :

1. Rensselaer Polytechnic Institute professor Georges Belfort wins biochemical engineering award
2. UTHealth School of Biomedical Informatics professor to be inducted to AIMBE College of Fellows
3. ASU professor named top in state of Arizona
4. UH engineering professors featured in consecutive issues of Science
5. Falling in love more scientific than you think, according to Syracuse University professor
6. NJIT professor helps make case in Science for better biodiversity
7. 1 step closer to a drug treatment for cystic fibrosis, MU professor says
8. USDA awards grant to GSU professor to study childhood obesity dynamics
9. UD Professor Emeritus wins Nobel Prize in Chemistry
10. Louisiana Tech professor partners with local schools to study menu nutrition
11. Nobel Prize for Professor Robert G. Edwards, Editor Emeritus of Reproductive BioMedicine Online
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/2/2016)... NEW YORK , June 2, 2016   The ... (Weather), is announcing Watson Ads, an industry-first capability in which ... advertising, by being able to ask questions via voice or ... Marketers have long ... with the consumer, that can be personal, relevant and valuable; ...
(Date:6/1/2016)... , June 1, 2016 ... in Election Administration and Criminal Identification to Boost Global ... a recently released TechSci Research report, " Global Biometrics ... Region, Competition Forecast and Opportunities, 2011 - 2021", the ... billion by 2021, on account of growing security concerns ...
(Date:5/20/2016)... MINNEAPOLIS , May 20, 2016  VoiceIt ... technology partnership with VoicePass. By working ... user experience.  Because VoiceIt and VoicePass take slightly ... two engines increases both security and usability. ... expressed excitement about this new partnership. ...
Breaking Biology News(10 mins):
(Date:6/24/2016)... , June 24, 2016 Epic Sciences ... detects cancers susceptible to PARP inhibitors by targeting ... cells (CTCs). The new test has already been ... in multiple cancer types. Over 230 ... damage response pathways, including PARP, ATM, ATR, DNA-PK ...
(Date:6/23/2016)... ... June 23, 2016 , ... ... its second eBook, “Clinical Trials Patient Recruitment and Retention Tips.” Partnering with experienced ... this eBook by providing practical tips, tools, and strategies for clinical researchers. , ...
(Date:6/23/2016)... TORONTO , June 23, 2016 /PRNewswire/ - ... Ontario biotechnology company, Propellon ... the development and commercialization of a portfolio of ... cancers. Epigenetic targets such as WDR5 represent an ... contribute significantly in precision medicine for cancer patients. ...
(Date:6/23/2016)... (PRWEB) , ... June 23, 2016 , ... ... Plate® YM (Yeast and Mold) microbial test has received AOAC Research Institute approval ... of microbial tests introduced last year,” stated Bob Salter, Vice President of Regulatory ...
Breaking Biology Technology: